Form 4 for BEAM Beam Therapeutics Inc.
Accepted 2024-12-19 00:00:00 ET · period of report 2024-12-17 · accession 0000950170-24-138447 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-12-19 | 2024-12-17 | BEAM | Ciaramella Giuseppe | Pres | M - OptEx | $0.67 | +53.5K | 162.7K | +49% | +$35.8K |
| D | 2024-12-19 | 2024-12-17 | BEAM | Ciaramella Giuseppe | Pres | M - OptEx | $0.00 | -53.5K | 6,505 | -89% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-17 | M | A | 53,500 | $0.67 | 162,650 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-12-17 | M | D | 53,500 | $0.00 | 6,505 | D | $0.67 · — to 2028-05-08 | 53,500 Common Stock | (F1) The shares subject to this stock option vested 25% on the first anniversary of the vesting commencement date, February 26, 2018, and the remaining shares vested in 36 substantially equal monthly installments thereafter. |